Pubblicazioni

1: Zaza G, Granata S, Rascio F, Pontrelli P, Dell'Oglio MP, Cox SN, Pertosa G, Grandaliano G, Lupo A. A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. BMC Med Genomics. 2013 May 10;6:17. doi: 10.1186/1755-8794-6-17. PubMed PMID: 23663527; PubMed Central PMCID: PMC3655909.  

2: EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB,  Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM,  Trotman ML, Wheeler DC, Parfrey PS. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov

3. PubMed PMID: 23121374.   3: Sirico ML, Guida B, Procino A, Pota A, Sodo M, Grandaliano G, Simone S, Pertosa G, Riccio E, Memoli B. Human mature adipocytes express albumin and this expression is not regulated by inflammation. Mediators Inflamm. 2012;2012:236796. doi: 10.1155/2012/236796. Epub 2012 May 15. PubMed PMID: 22675238; PubMed Central PMCID: PMC3362193.  

4: Simone S, Cosola C, Loverre A, Cariello M, Sallustio F, Rascio F, Gesualdo L,  Schena FP, Grandaliano G, Pertosa G. BMP-2 induces a profibrotic phenotype in adult renal progenitor cells through Nox4 activation. Am J Physiol Renal Physiol. 2012 Jul 1;303(1):F23-34. doi: 10.1152/ajprenal.00328.2011. Epub 2012 Apr 11. PubMed PMID: 22496405.  

5: Cariello M, Simone S, Loverre A, Gigante M, Incampo F, Pietanza S, Colucci M,  Schena FP, Gesualdo L, Grandaliano G, Pertosa G. Coagulation activation is associated with nicotinamide adenine dinucleotide phosphate oxidase-dependent reactive oxygen species generation in hemodialysis patients. Antioxid Redox Signal. 2012 Mar 1;16(5):428-39. doi: 10.1089/ars.2011.4062. Epub 2011 Dec 22. PubMed PMID: 22191478.  

6: Ciccone MM, Cortese F, Fiorella A, Scicchitano P, Cito F, Quistelli G, Pertosa G, D'Agostino R, Guida P, Favale S. The clinical role of contrast-enhanced ultrasound in the evaluation of renal artery stenosis and diagnostic superiority  as compared to traditional echo-color-Doppler flow imaging. Int Angiol. 2011 Apr;30(2):135-9. PubMed PMID: 21427650.  

7: Monno R, Pertosa G, Grandaliano G, Fumarola L, Giannelli G, Simone S. Relation of C. pneumoniae antibodies to inflammation and atherosclerosclerosis in dialysis patients. Panminerva Med. 2010 Dec;52(4):283-8. PubMed PMID: 21183888.  

8: Dalfino G, Simone S, Porreca S, Cosola C, Balestra C, Manno C, Schena FP, Grandaliano G, Pertosa G. Bone morphogenetic protein-2 may represent the molecular link between oxidative stress and vascular stiffness in chronic kidney  disease. Atherosclerosis. 2010 Aug;211(2):418-23. doi: 10.1016/j.atherosclerosis.2010.04.023. Epub 2010 Apr 29. PubMed PMID: 20537331.  

9: Montinaro V, Iaffaldano GP, Granata S, Porcelli P, Todarello O, Schena FP, Pertosa G. Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. Clin Nephrol. 2010 Jan;73(1):36-43. PubMed PMID: 20040350.  

10: Castellano G, Di Vittorio A, Dalfino G, Loverre A, Marrone D, Simone S, Schena FP, Pertosa G, Grandaliano G. Pentraxin 3 and complement cascade activation in the failure of arteriovenous fistula. Atherosclerosis. 2010 Mar;209(1):241-7. doi: 10.1016/j.atherosclerosis.2009.08.044. Epub 2009 Aug 31. PubMed PMID: 19772962.  

11: Granata S, Zaza G, Simone S, Villani G, Latorre D, Pontrelli P, Carella M, Schena FP, Grandaliano G, Pertosa G. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics. 2009 Aug 21;10:388. doi: 10.1186/1471-2164-10-388. PubMed PMID: 19698090; PubMed Central PMCID: PMC2737002.  

12: Morrone LF, Mazzaferro S, Russo D, Aucella F, Cozzolino M, Facchini MG, Galfrè A, Malberti F, Mereu MC, Nordio M, Pertosa G, Santoro D; CPCP Study Investigators. Interaction between parathyroid hormone and the Charlson comorbidity index on survival of incident haemodialysis patients. Nephrol Dial Transplant. 2009 Sep;24(9):2859-65. doi: 10.1093/ndt/gfp170. Epub 2009 Apr 15. PubMed PMID: 19369685.  

13: Pertosa G, Simone S, Ciccone M, Porreca S, Zaza G, Dalfino G, Memoli B, Procino A, Bonomini M, Sirolli V, Castellano G, Gesualdo L, Ktena M, Schena FP, Grandaliano G. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis? Am J Kidney Dis. 2009 Mar;53(3):467-74. doi: 10.1053/j.ajkd.2008.10.046. Epub 2009 Jan 23. PubMed PMID: 19167798.  

14: Zaza G, Pontrelli P, Pertosa G, Granata S, Rossini M, Porreca S, Staal FJ, Gesualdo L, Grandaliano G, Schena FP. Dialysis-related systemic microinflammation is associated with specific genomic patterns. Nephrol Dial Transplant. 2008 May;23(5):1673-81. Epub 2007 Nov 29. PubMed PMID: 18048420.  

15: Memoli B, Procino A, Calabrò P, Esposito P, Grandaliano G, Pertosa G, Prete MD, Andreucci M, Lillo SD, Ferulano G, Cillo C, Savastano S, Colao A, Guida B. Inflammation may modulate IL-6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor. Am J Physiol Endocrinol  Metab. 2007 Oct;293(4):E1030-5. Epub 2007 Jul 24. PubMed PMID: 17652155.  

16: Marrone D, Pertosa G, Simone S, Loverre A, Capobianco C, Cifarelli M, Memoli  B, Schena FP, Grandaliano G. Local activation of interleukin 6 signaling is associated with arteriovenous fistula stenosis in hemodialysis patients. Am J Kidney Dis. 2007 May;49(5):664-73. PubMed PMID: 17472849.  

17: Sirolli V, Amoroso L, Pietropaolo M, Grandaliano G, Pertosa G, Bonomini M. Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? Int J Immunopathol Pharmacol. 2006 Jul-Sep;19(3):461-70. Review. PubMed PMID: 17026832.  

18: Pertosa G, Simone S, Soccio M, Marrone D, Gesualdo L, Schena FP, Grandaliano  G. Coagulation cascade activation causes CC chemokine receptor-2 gene expression  and mononuclear cell activation in hemodialysis patients. J Am Soc Nephrol. 2005  Aug;16(8):2477-86. Epub 2005 Jun 23. Erratum in: J Am Soc Nephrol. 2006 May;17(5):1489. J Am Soc Nephrol. 2006 Feb;17(2):591. PubMed PMID: 15976001.  

19: Memoli B, Grandaliano G, Soccio M, Procino A, Pertosa G. [The IL-6 soluble receptors in hemodialyzed patients]. G Ital Nefrol. 2004 Nov-Dec;21 Suppl 30:S117-21. Italian. PubMed PMID: 15747293.   

20: Memoli B, Grandaliano G, Soccio M, Postiglione L, Guida B, Bisesti V, Esposito P, Procino A, Marrone D, Michael A, Andreucci M, Schena FP, Pertosa G. In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release  in ESRD. J Am Soc Nephrol. 2005 Apr;16(4):1099-107. Epub 2005 Feb 16. PubMed PMID: 15716332.  

21: Pertosa G, Grandaliano G, Simone S, Soccio M, Schena FP. Inflammation and carnitine in hemodialysis patients. J Ren Nutr. 2005 Jan;15(1):8-12. PubMed PMID: 15647999.  

22: Pertosa G, Simone S, Soccio M, Marrone D, Grandaliano G. [Chronic inflammation and cardiovascular risk in hemodialysis]. G Ital Nefrol. 2003 Nov-Dec;20(6):631-40. Review. Italian. PubMed PMID: 14732917.  

23: Stallone G, Angelini P, Cataldi G, Pallotta G, Sacchetti A, Pertosa G, Schena FP, Gesualdo L. [Evaluation of quality of life by improving the uraemic anaemia status]. G Ital Nefrol. 2003 Sep-Oct;20(5):478-83. Italian. PubMed PMID: 14634963.  

24: Grandaliano G, Teutonico A, Allegretti A, Losappio R, Mancini A, Gesualdo L,  Schena FP, Pertosa G. The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis. Kidney Int. 2003 Aug;64(2):715-9. PubMed PMID: 12846770.  

25: Strippoli GF, Montinaro V, Manno C, Palma M, Lepore V, Schena FP, Pertosa GB. [Chorea in hemodialysis: Is chorea just a neurological syndrome or is it related  to uremia or dialysis?]. G Ital Nefrol. 2002 Sep-Oct;19(5):575-84. Italian. PubMed PMID: 12439848.  

26: Pertosa G, Grandaliano G, Soccio M, Martino C, Gesualdo L, Schena FP. Vitamin E-modified filters modulate Jun N-terminal kinase activation in peripheral blood  mononuclear cells. Kidney Int. 2002 Aug;62(2):602-10. PubMed PMID: 12110024.  

27: Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney Int Suppl. 2000 Aug;76:S104-11. Review. PubMed PMID: 10936806.   28: Pertosa G, Grandaliano G, Valente M, Montinaro V, Soccio M, Gesualdo L, Schena FP. In vivo evaluation of biocompatibility of a new dialyzer employing the vitamin E-modified cellulose membrane 'Excebrane E': study of mechanisms involved in mononuclear cell activation. Contrib Nephrol. 1999;127:200-7. PubMed PMID: 10629789.  

29: Gesualdo L, Grandaliano G, Mascia L, Pertosa G, Schena FP. Acute renal failure in critically ill patients. Intensive Care Med. 1999 Oct;25(10):1188-90.  Review. PubMed PMID: 10551984.   30: Pertosa G, Grandaliano G, Gesualdo L, Ranieri E, Monno R, Schena FP. Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes. Kidney Int. 1998 Aug;54(2):570-9. PubMed PMID: 9690225.  

31: Gesualdo L, Pertosa G, Grandaliano G, Schena FP. Cytokines and bioincompatibility. Nephrol Dial Transplant. 1998 Jul;13(7):1622-6. Review. PubMed PMID: 9681699.  

32: Manno C, Pertosa G, Schena FP. [DRG's and cost/efficacy indicators in nephrology and dialysis. Results at a hospital division]. Recenti Prog Med. 1998  Feb;89(2):55-62. Italian. PubMed PMID: 9558906.  

33: Pertosa G, Gesualdo L, Bottalico D, Schena FP. Endotoxins modulate chronically tumour necrosis factor alpha and interleukin 6 release by uraemic monocytes. Nephrol Dial Transplant. 1995;10(3):328-33. PubMed PMID: 7792027.  

34: Pertosa G, Tarantino EA, Gesualdo L, Montinaro V, Schena FP. C5b-9 generation and cytokine production in hemodialyzed patients. Kidney Int Suppl. 1993 Jun;41:S221-5. PubMed PMID: 8320926.  

35: Pertosa G, Gesualdo L, Tarantino EA, Ranieri E, Bottalico D, Schena FP. Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. Kidney Int Suppl. 1993 Jan;39:S149-53. Review. PubMed PMID: 8468918.   36: Pertosa G, Marfella C, Tarantino EA, Di Cillo M, Manno C, Russo R, Schena FP. Involvement of peripheral blood monocytes in haemodialysis: in vivo induction of  tumour necrosis factor alpha, interleukin 6 and beta 2-microglobulin. Nephrol Dial Transplant. 1991;6 Suppl 2:18-23. PubMed PMID: 1866063.  

37: Pertosa G, Pastore A, Schena FP. Influence of different dialyzer membranes on plasma fibronectin levels in hemodialyzed patients. Int J Artif Organs. 1989 Jan;12(1):36-40. PubMed PMID: 2925259.  

38: Pertosa G, Mastrolitti G, Späth PJ, Fracasso AR, Manno C, Schena FP. Effect of fibronectin on C3b and Fc receptor-mediated phagocytosis by peripheral blood monocytes in uraemic patients. Nephrol Dial Transplant. 1989;4(1):15-20. PubMed PMID: 2522602.   39: Schena FP, Pertosa G. Fibronectin and the kidney. Nephron. 1988;48(3):177-82. Review. PubMed PMID: 3281043.  

40: Schena FP, Pertosa G, Germinario C. Plasma fibronectin levels in patients with chronic uremia. Nephron. 1986;44(4):320-3. PubMed PMID: 3540692.  

41: Schena FP, Pertosa G, Stanziale P, Germinario C, Balletta M, Andreucci VE. Serum profiles of the regulatory complement proteins during the progression of renal damage in human glomerulonephritis. Nephron. 1986;44(4):272-6. PubMed PMID: 2948131.  

42: Schena FP, Pertosa G, Pastore A, Manno C, Pastore G. Plasma fibronectin concentrations in hemodialyzed patients. Influence of different dialyzers. Life Support Syst. 1985 Jan-Mar;3(1):83-5. PubMed PMID: 3990357.  

43: Pastore G, Schena FP, Angarano G, Monno L, Santantonio T, Pertosa G, Schiraldi O. Circulating immune complexes in HBsAg-positive and HBsAg-negative chronic liver diseases. Ric Clin Lab. 1984 Jan-Mar;14(1):29-35. PubMed PMID: 6427879.  

44: Schena FP, Pertosa G, Pastore A, De Tommasi A, Montagna MT, Bonomo L. Circulating immune complexes in infected ventriculoatrial and ventriculoperitoneal shunts. J Clin Immunol. 1983 Apr;3(2):173-7. PubMed PMID: 6853685.  

45: Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis. Clin Nephrol. 1982 Nov;18(5):240-6. PubMed PMID: 7151338.  

46: Schena FP, Pertosa G, Vox E, Mastrolitti G. [Diagnostic and prognostic value  of complement in nephrotic syndromes]. Minerva Nefrol. 1981 Jul-Sep;28(3):387-92. Review. Italian. PubMed PMID: 7036019.  

47: Stanziale P, Pertosa G, Pecoraro C, Vox E, Gallo R, Grasso C, Schena FP, Andreucci VE. [Biological significance of the nephritic factor in membrano-proliferative glomerulonephritis]. Minerva Nefrol. 1981 Apr-Jun;28(2):127-31. Italian. PubMed PMID: 6912953.  

48: Pertosa G, Pecoraro C, Laraia E, Stanziale P, Gallo R, Andreucci VE, Schena FP. [Determination of C3 in primary and secondary glomerulonephritis]. Minerva Nefrol. 1981 Jan-Mar;28(1):11-4. Italian. PubMed PMID: 7290504.  

49: Schena FP, Pertosa G, Vox E, Bonomo L. Activation of the alternative complement pathway by unidentified substances in human glomerulonephritis. Nephron. 1981;27(1):9-14. PubMed PMID: 6908651.  

50: Schena FP, Pertosa G, Manno C, Losuriello V, Pastore A. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data]. Minerva Chir. 1980 May 31;35(10):709-14. Italian. PubMed PMID: 7005726.  

51: Schena FP, Losuriello V, Pertosa G, Penza R. The clinical value of serum immune complexes in human glomerulonephritis. Ric Clin Lab. 1980 Jan-Mar;10(1):99-105. PubMed PMID: 7466167.  

52: Pertosa G, Vox E, Pastore A, Schena FP. [Behavior of the nephritic factor and of circulating immune complexes in cryoglobulinemic glomerulonephritis]. Minerva  Nefrol. 1979 Jul-Sep;26(3):251-5. Italian. PubMed PMID: 262262.